Advertisement

Immunologic Research

, Volume 62, Issue 1, pp 1–2 | Cite as

Comment on: Evolution of multiple sclerosis in France since the beginning of hepatitis B vaccination

  • Alfred SpiraEmail author
  • Pierre Bégué
  • André Aurengo
Letter to the Editor

Sir

We would like to comment on the interesting paper by Le Houe’zec concerning a relationship between hepatitis B (HB) vaccination and a subsequent risk of multiple sclerosis (MS) recently published in your Journal.1 The author states that this link is proven and that it could be causal.

Considering the immunization mass campaign which occurred in France between 1994 and 1997 as a “natural experiment” is an excellent idea. But to consider “quasi experiment” as an experimental design and to eliminate possible confounders, the analysis must rely on very precise data, both on population at risk as a whole and on individuals who have been or not been vaccinated.

The paper relies on an ecological analysis derived from two sets of medico-administrative data bases, namely those of the French health insurance system (CNAM) and of spontaneous post-vaccine reports to the French pharmacovigilance agency, which both concern the French population as a whole and no data collected on individuals....

Keywords

Multiple Sclerosis Vigilance Level Ecological Fallacy Multiple Sclerosis Case Sylvan 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Copyright information

© Springer Science+Business Media New York 2015

Authors and Affiliations

  1. 1.Académie nationale de MédecineParisFrance

Personalised recommendations